Austin D. Kim Acadia Pharmaceuticals Inc (ACAD) insider trading activity

Austin D. Kim is EVP,General Counsel, Secretary of ACADIA PHARMACEUTICALS INC. Currently has a direct ownership of 46,901 shares of ACAD, which is worth approximately $684,285. The most recent transaction as insider was on Jan 08, 2024, when has been sold 590 shares (Common Stock) at a price of $29.96 per share, resulting in proceeds of $17,676. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.9K

0% 3M change

2.28% 12M change

Total Value Held $684,285

AUSTIN D. KIM Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 08 2024	SELL Open market or private sale	$17,676 $29.96 p/Share	590 Reduced 1.24%	46,901 Common Stock
Jan 06 2024	BUY Exercise of conversion of derivative security	-	1,634 Added 3.33%	47,491 Common Stock
Oct 06 2023	SELL Open market or private sale	$359,463 $21.96 p/Share	16,369 Reduced 26.31%	45,857 Common Stock
Oct 05 2023	BUY Exercise of conversion of derivative security	-	36,174 Added 36.76%	62,226 Common Stock
May 01 2023	SELL Open market or private sale	$19,422 $21.18 p/Share	917 Reduced 3.47%	25,513 Common Stock
Apr 29 2023	BUY Exercise of conversion of derivative security	-	3,005 Added 10.21%	26,430 Common Stock
Apr 06 2023	SELL Open market or private sale	$26,440 $18.16 p/Share	1,456 Reduced 5.85%	23,425 Common Stock
Apr 05 2023	BUY Exercise of conversion of derivative security	-	4,773 Added 16.1%	24,881 Common Stock
Feb 24 2023	SELL Open market or private sale	$15,080 $18.78 p/Share	803 Reduced 3.84%	20,108 Common Stock
Feb 23 2023	BUY Exercise of conversion of derivative security	-	2,214 Added 9.57%	20,911 Common Stock
Jan 09 2023	SELL Open market or private sale	$10,089 $17.13 p/Share	589 Reduced 3.05%	18,697 Common Stock
Jan 06 2023	BUY Exercise of conversion of derivative security	-	1,633 Added 7.81%	19,286 Common Stock
May 02 2022	SELL Open market or private sale	$16,253 $18.18 p/Share	894 Reduced 5.07%	16,742 Common Stock
Apr 29 2022	BUY Exercise of conversion of derivative security	-	3,005 Added 14.56%	17,636 Common Stock
Feb 23 2022	SELL Open market or private sale	$18,612 $23.8 p/Share	782 Reduced 5.07%	14,631 Common Stock
Feb 23 2022	BUY Exercise of conversion of derivative security	-	2,213 Added 12.56%	15,413 Common Stock
Jan 06 2022	SELL Open market or private sale	$13,231 $23.05 p/Share	574 Reduced 4.17%	13,200 Common Stock
Jan 06 2022	BUY Exercise of conversion of derivative security	-	1,633 Added 10.6%	13,774 Common Stock
Apr 30 2021	SELL Open market or private sale	$21,428 $20.33 p/Share	1,054 Reduced 8.48%	11,371 Common Stock
Apr 29 2021	BUY Exercise of conversion of derivative security	-	3,005 Added 19.48%	12,425 Common Stock
Feb 04 2021	SELL Open market or private sale	$106,635 $50.61 p/Share	2,107 Reduced 17.53%	9,911 Common Stock
Feb 04 2021	BUY Grant, award, or other acquisition	-	6,009 Added 33.33%	12,018 Common Stock
Jan 06 2021	SELL Open market or private sale	$36,165 $53.34 p/Share	678 Reduced 10.94%	5,518 Common Stock
Jan 06 2021	BUY Exercise of conversion of derivative security	-	1,633 Added 20.86%	6,196 Common Stock
Oct 27 2020	SELL Open market or private sale	$394,625 $45.1 p/Share	8,750 Reduced 69.44%	3,851 Common Stock

ADK

Austin D. Kim

EVP,General Counsel, Secretary

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACAD shares.

Notify only if

Value

Insider Trading

Get notified when an Acadia Pharmaceuticals Inc insider buys or sells ACAD shares.

Notify only if

Operation

Value

Type

News

Receive news related to ACADIA PHARMACEUTICALS INC

Track Activities on ACAD

Account